BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 2323522)

  • 1. Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes.
    Layer P; Jansen JB; Cherian L; Lamers CB; Goebell H
    Gastroenterology; 1990 May; 98(5 Pt 1):1311-9. PubMed ID: 2323522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).
    Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R
    Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
    Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
    Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of enzyme activities in duodenal aspirate following injection of secretin, caerulein, and cholecystokinin.
    Vandermeers-Piret MC; Vandermeers A; Rathé J; Christophe J; Van der Hoeden R; Wettendorff P; Delcourt A
    Digestion; 1974; 10(3):191-204. PubMed ID: 4850176
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival of human pancreatic enzymes during small bowel transit: effect of nutrients, bile acids, and enzymes.
    Holtmann G; Kelly DG; Sternby B; DiMagno EP
    Am J Physiol; 1997 Aug; 273(2 Pt 1):G553-8. PubMed ID: 9277437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of pancreatic enzymes during small intestinal aboral transit in humans.
    Layer P; Go VL; DiMagno EP
    Am J Physiol; 1986 Oct; 251(4 Pt 1):G475-80. PubMed ID: 2429560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
    Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R
    Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of camostat, a synthetic protease inhibitor, on endocrine and exocrine pancreas of the rat.
    Müller MK; Goebell H; Alfen R; Ehlers J; Jäger M; Plümpe H
    J Nutr; 1988 May; 118(5):645-50. PubMed ID: 2452864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabexate and camostat, synthetic proteinase inhibitors, as direct inducing factors of water and bicarbonate secretion in the isolated and blood-perfused dog pancreas.
    Horiuchi A; Iwatsuki K; Yonekura H; Ren LM; Chiba S
    J Pharmacol Exp Ther; 1990 Jan; 252(1):320-6. PubMed ID: 1688943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intraduodenal proteases in plasma cholecystokinin and pancreaticobiliary responses to protein and amino acids.
    Thimister PW; Hopman WP; Sloots CE; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
    Gastroenterology; 1996 Feb; 110(2):567-75. PubMed ID: 8566605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of proteinase inhibitor camostat on exocrine pancreas in fed and fasted rats.
    Otsuki M; Tani S; Fujii M; Nakamura T; Okabayashi Y; Koide M
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R896-901. PubMed ID: 7694489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
    Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
    Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precocious alteration of digestive enzyme activities in small intestine and pancreas by chronic oral administration of protease inhibitor in suckling rats.
    Harada E; Syuto B
    Comp Biochem Physiol A Comp Physiol; 1991; 100(2):467-72. PubMed ID: 1685962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both free and complexed trypsin inhibitors stimulate pancreatic secretion and change duodenal enzyme levels.
    Pusztai A; Grant G; Bardocz S; Baintner K; Gelencsér E; Ewen SW
    Am J Physiol; 1997 Feb; 272(2 Pt 1):G340-50. PubMed ID: 9124359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide.
    Miyasaka K; Guan DF; Liddle RA; Green GM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G175-81. PubMed ID: 2764106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of exogenous application of pancreatic extracts on endogenous pancreatic enzyme secretion.
    Mössner J; Stange JH; Ewald M; Kestel W; Fischbach W
    Pancreas; 1991 Nov; 6(6):637-44. PubMed ID: 1723524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
    Watanabe S; Takeuchi T; Chey WY
    Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonparallel secretion of enzymes in human duodenal juice and pure pancreatic juice collected by endoscopic retrograde catheterization of the papilla.
    Dagorn JC; Sahel J; Sarles H
    Gastroenterology; 1977 Jul; 73(1):42-5. PubMed ID: 863199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback control of pancreatic secretion in rats. Role of gastric acid secretion.
    Bilski J; Konturek PK; Krzyzek E; Konturek SJ
    J Physiol Pharmacol; 1992 Sep; 43(3):237-57. PubMed ID: 1493255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pattern of enzyme secretion by rat pancreas during repeated trypsin inhibitor treatment.
    Keim V; Göke B; Adler G
    Am J Physiol; 1988 Aug; 255(2 Pt 1):G236-41. PubMed ID: 2457325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.